Haemonetics Corporation (HAE)
-NYSE 42.35 
0.36(0.84%) 4:03PM EDT|After Hours
:
42.35 0.00 (0.00%) 4:32PM EDT
| Prev Close: | 42.71 |
|---|
| Open: | 42.71 |
|---|
| Bid: | 41.33 x 200 |
|---|
| Ask: | 46.17 x 100 |
|---|
| 1y Target Est: | 47.63 |
|---|
| Beta: | 0.7 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 42.21 - 42.84 |
|---|
| 52wk Range: | 33.51 - 44.44 |
|---|
| Volume: | 207,692 |
|---|
| Avg Vol (3m): | 316,875 |
|---|
| Market Cap: | 2.16B |
|---|
| P/E (ttm): | 57.23 |
|---|
| EPS (ttm): | 0.74 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Merge iConnect Solutions Wins ClientZacks(Wed 2:20PM EDT)
- InPlay: Haemonetics announces next steps in manufacturing transformation; selects Sanmina (SANM) the future production of medical devices currently manufactured in Braintree, MassachusettsBriefing.com(Wed 1:54PM EDT)
- Haemonetics Announces Next Steps in Manufacturing TransformationPR Newswire(Wed 1:53PM EDT)
- HAEMONETICS CORP Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Other Events, Financial StateEDGAR Online(Wed 10:24AM EDT)
- MDT Expands Spine-Line in EuropeZacks(Wed 8:30AM EDT)
- BSX Commences U.S. INTREPID TrialZacks(Tue, Jun 18)
- German Court Rules in Favor of MDTZacks(Mon, Jun 17)
- Positive Data for COV's SolitaireZacks(Mon, Jun 17)
- Insiders Buy the Holdings of XSLV ETFat Forbes(Mon, Jun 17)
- LIFE Continues Korean ExpansionZacks(Fri, Jun 14)
- FDA Nod for STJ's Ellipse & AssuraZacks(Thu, Jun 13)
- CardioNet Skyrockets on New DealZacks(Wed, Jun 12)
- Zimmer Stays at NeutralZacks(Tue, Jun 11)
- Qiagen Attempts to Expand NGS PlatformZacks(Tue, Jun 11)
- Symmetry Provides Dismal 2013 ViewZacks(Tue, Jun 11)
Key Statistics
| Forward P/E (1 yr): | 15.86 |
|---|
| P/S (ttm): | 2.45 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Mar-14)
: | 2.34 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.47 |
|---|
| Mean Recommendation*: | 2.2 |
|---|
| PEG Ratio (5 yr expected): | 1.31 |
|---|
Business Summary
Haemonetics Corporation develops and manufactures automated blood component collection and surgical blood salvage devices for plasma fractionators, blood collectors, and hospitals.
View More